Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 6 de 6
Filtrar
1.
Acta Obstet Gynecol Scand ; 95(2): 135-43, 2016 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-26577070

RESUMO

Worldwide, 98% of stillbirths occur in low-income countries (LIC), where stillbirth rates are ten-fold higher than in high-income countries (HIC). Although most HIC stillbirths occur prenatally, in LIC most stillbirths occur at term and during labor/delivery. Conditions causing stillbirths include those of maternal origin (obstructed labor, trauma, antepartum hemorrhage, preeclampsia/eclampsia, infection, diabetes, other maternal diseases), and fetal origin (fetal growth restriction, fetal distress, cord prolapse, multiples, malpresentations, congenital anomalies). In LIC, aside from infectious origins, most stillbirths are caused by fetal asphyxia. Stillbirth prevention requires recognition of maternal conditions, and care in a facility where fetal monitoring and expeditious delivery are possible, usually by cesarean section (CS). Of major causes, only syphilis and malaria can be managed prenatally. Targeting single conditions or interventions is unlikely to substantially reduce stillbirth. To reduce stillbirth rates, LIC must implement effective modern antepartum and intrapartum care, including fetal monitoring and CS.


Assuntos
Morte Fetal/prevenção & controle , Pobreza , Complicações na Gravidez/prevenção & controle , Cuidado Pré-Natal/normas , Natimorto , Parto Obstétrico/métodos , Feminino , Doenças Fetais/mortalidade , Humanos , Mortalidade Materna , Tocologia , Gravidez , Ressuscitação/métodos , Fatores de Risco
2.
J Heart Valve Dis ; 17(5): 526-32, 2008 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-18980086

RESUMO

BACKGROUND AND AIM OF THE STUDY: Patients with mechanical heart valves require anticoagulation which is associated with significant maternal mortality (1-4%) and fetal complications (31%) in pregnancy. The study aim was to identify anticoagulant protocols and outcomes for pregnant women undergoing heart valve replacement (HVR) in the United Kingdom. METHODS: Women aged between 18 and 45 years and registered with the United Kingdom Heart Valve Registry (UKHVR) each completed a questionnaire, and their obstetric notes were reviewed. The data analyzed included valve type (mechanical, bioprosthetic, homograft), valve site (mitral, aortic, tricuspid, pulmonary), anticoagulation at confirmation of pregnancy, between 6-12 weeks and from 12 weeks to term, delivery, maternal and fetal outcomes, and cause of death. The summary statistics and a descriptive review of the findings are reported. RESULTS: Of 2,532 women eligible for the study, 922 responded. Among these women, 72 became pregnant, with 60 pregnancies in the mechanical valve (MV) group and 45 in the tissue valve (TV) group. Three anticoagulation regimes were used during early pregnancy: unfractionated heparin (UFH), low-molecular-weight heparin (LMWH) or warfarin. All women received warfarin in the second trimester and heparin for delivery. Live births were recorded in 30% of MV pregnancies and in 60% of TV pregnancies. Miscarriage rates differed markedly (37% MV versus 2% TV). Fetal outcome was poorest in the warfarin-only group, with embryopathy occurring at a dose level of 6 mg. The maternal outcomes did not differ significantly among groups. High-dose heparin during the first trimester and for delivery was effective for the majority of mechanical valves. CONCLUSION: The study results illustrate the diverse and uncertain manner in which UKHVR patients are managed during pregnancy. A national notification system would record much-needed prospective information on anticoagulation and pregnancy outcomes, thus aiding evidence-based management.


Assuntos
Anticoagulantes/uso terapêutico , Bioprótese , Implante de Prótese de Valva Cardíaca , Complicações Pós-Operatórias/tratamento farmacológico , Complicações Cardiovasculares na Gravidez/tratamento farmacológico , Aborto Espontâneo/mortalidade , Adolescente , Adulto , Anticoagulantes/efeitos adversos , Causas de Morte , Relação Dose-Resposta a Droga , Feminino , Doenças Fetais/induzido quimicamente , Doenças Fetais/mortalidade , Insuficiência Cardíaca/mortalidade , Heparina/efeitos adversos , Heparina/uso terapêutico , Heparina de Baixo Peso Molecular/efeitos adversos , Heparina de Baixo Peso Molecular/uso terapêutico , Humanos , Pessoa de Meia-Idade , Complicações Pós-Operatórias/mortalidade , Gravidez , Complicações Cardiovasculares na Gravidez/mortalidade , Resultado da Gravidez , Fatores de Risco , Reino Unido , Varfarina/efeitos adversos , Varfarina/uso terapêutico
3.
Reprod Domest Anim ; 43(3): 339-345, 2008 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-18086254

RESUMO

Perinatal mortality and stillbirths were investigated in an extensively managed herd of Friesian cows and heifers calving over a 2-year period: 504 cows were calved and 215 heifers. Cows were bred to Friesian and Jersey bulls using natural service. The perinatal fetal mortality rate was 7.5% for cows and 30% for heifers. An experienced stockman managed these calvings and veterinary assistance was required only on nine occasions. All stillborn fetuses were examined post-mortem by the Veterinary Laboratories Agency, Carmarthen and no infectious agent was identified on any occasion. Thyroid hyperplasia was found in two fetuses. In blood samples taken from 10 late pregnant heifers, mean glutathione peroxidase values were 7.9 +/- 1.7 IU/ml Packed Cell Volume (PCV). Tissues from eight fetuses were submitted to the University of Liverpool for histopathological examination; all presented lesions consistent with myocardial degeneration and necrosis of the left ventricle. Following treatment of 205 late pregnant heifers with sodium selenite and vitamin E, the overall perinatal mortality rate in these cattle fell to below 11%.


Assuntos
Fenômenos Fisiológicos da Nutrição Animal , Cardiomiopatias/veterinária , Doenças dos Bovinos/mortalidade , Complicações na Gravidez/veterinária , Selênio/deficiência , Deficiência de Vitamina E/veterinária , Animais , Cardiomiopatias/mortalidade , Cardiomiopatias/patologia , Bovinos , Doenças dos Bovinos/patologia , Feminino , Doenças Fetais/mortalidade , Doenças Fetais/patologia , Doenças Fetais/veterinária , Necrose/mortalidade , Necrose/patologia , Necrose/veterinária , Mortalidade Perinatal , Gravidez , Complicações na Gravidez/mortalidade , Complicações na Gravidez/patologia , Selênio/uso terapêutico , Natimorto/veterinária , Vitamina E/uso terapêutico , Deficiência de Vitamina E/complicações , Deficiência de Vitamina E/mortalidade , Deficiência de Vitamina E/patologia
4.
Recenti Prog Med ; 98(12): 607-10, 2007 Dec.
Artigo em Italiano | MEDLINE | ID: mdl-18369034

RESUMO

The section of the Italian law on the termination of pregnancy (no. 194/1978) regarding late termination is revised and discussed in the light of the various options that could be offered to parents. Besides recent suggestions to apply time limits, the author reviews an alternative therapeutic option, considered the only feasible revision of the law which calls for strong involvement by the neonatologist and close collaboration with the obstetrician: the offer of palliative care for foetus/neonate and parents.


Assuntos
Aborto Legal/legislação & jurisprudência , Doenças Fetais/terapia , Feto/anormalidades , Neonatologia , Cuidados Paliativos , Aborto Legal/ética , Feminino , Doenças Fetais/mortalidade , Idade Gestacional , Humanos , Recém-Nascido , Itália , Masculino , Neonatologia/ética , Neonatologia/legislação & jurisprudência , Cuidados Paliativos/ética , Gravidez , Complicações na Gravidez/terapia , Diagnóstico Pré-Natal
5.
J Pediatr Surg ; 36(5): 739-44, 2001 May.
Artigo em Inglês | MEDLINE | ID: mdl-11329579

RESUMO

PURPOSE: Congenital diaphragmatic hernia (CDH) is associated with thickened pulmonary arteries (PA) contributing to pulmonary hypertension. In the current study, the effects of antenatal glucocorticoids and reversible tracheal occlusion (TO) on PA structure were assessed in a hypoplastic lung model. METHODS: A left-sided CDH was created in fetal lambs at 80 days gestation, TO at 108 days, and release of the occlusion (TR) at 129 days. All were given 1 dose of maternal glucocorticoids at 135 days. At 136 days (term, 145 days), the fetus was delivered by cesarian section. CDH (n = 7), CDH + TO (n = 6), CDH + TO + TR (n = 6), and unoperated twin controls (n = 16) were compared. Outcome measurements were (1) lung growth, represented by lung weight to body weight ratio (LW/BW), (2) lung structural maturation, which is inversely proportional to mean terminal bronchiole density (MTBD), (3) PA medial and adventitial areas (square micrometers), (4) lung capillary load, which is the ratio of vessel surface area (SA) to tissue SA ratio. RESULTS: CDH lungs were hypoplastic with a low LW/BW and high MTBD. The small PAs (<75 microm) of CDH had an increased medial area, indicating increased muscle mass and an increased adventitial area. CDH + TO +/- TR increased LW/BW and achieved normal structural lung maturity with a low MTBD. Only CDH + TO thinned the PA medial area closer to control values. The adventitial area remained thick in CDH +/- TO +/- TR when compared with controls. All 4 groups had similar capillary load. CONCLUSIONS: TO may be especially important for PA remodeling in the latter part of gestation, because TR 1 week before delivery prevents thinning of the small PAs in CDH. The shaping achieved by TO in terms of lung growth, structural maturity, and pulmonary artery medial area thinning may prove beneficial in lessening the severity of the associated pulmonary hypertension in CDH.


Assuntos
Anti-Inflamatórios/uso terapêutico , Oclusão com Balão/métodos , Betametasona/uso terapêutico , Modelos Animais de Doenças , Doenças Fetais/terapia , Glucocorticoides/uso terapêutico , Hérnia Diafragmática/terapia , Hérnias Diafragmáticas Congênitas , Pulmão/anormalidades , Pulmão/efeitos dos fármacos , Síndrome da Persistência do Padrão de Circulação Fetal/terapia , Cuidado Pré-Natal/métodos , Artéria Pulmonar/anormalidades , Artéria Pulmonar/efeitos dos fármacos , Traqueia , Animais , Oclusão com Balão/instrumentação , Terapia Combinada , Avaliação Pré-Clínica de Medicamentos , Doenças Fetais/mortalidade , Maturidade dos Órgãos Fetais , Idade Gestacional , Hérnia Diafragmática/mortalidade , Humanos , Recém-Nascido , Pulmão/crescimento & desenvolvimento , Tamanho do Órgão , Síndrome da Persistência do Padrão de Circulação Fetal/mortalidade , Artéria Pulmonar/crescimento & desenvolvimento , Ovinos , Análise de Sobrevida , Resultado do Tratamento
6.
Tierarztl Prax ; 21(3): 233-8, 1993 Jun.
Artigo em Alemão | MEDLINE | ID: mdl-8346526

RESUMO

An investigation was carried out upon occurrence and course of infectious and non infectious diseases as well as the mortality in foals born and raised at the State Stud Marbach/Lauter between 1982 and 1991. The foals have been investigated from birth to weaning, they consisted of 177 Thoroughbred Arabians and 285 German Warmblood foals (total 462 foals). The diseases were divided into pre-, peri- and postnatal according to their known or assumed cause and onset. There was a preponderance of prenatal diseases (11.25%) whereas the perinatal rate was 1.30% and the postnatal rate of diseases was 8.66%. The rate of infectious diseases increased from the pre- to the postnatal period of life. A comparison between the two breeds showed that 9% of the Arabian foals suffered from infectious diseases whereas only 4.9% of the Warmblood foals were similarly affected. This is probably linked to the lower level of colostral immunoglobulins in the Arab herd, as previously shown by us. The measurement of mare colostral and foal serum IgG as well as the paramunisation of neonatal and weaned foals are important factors in the prevention of infectious diseases.


Assuntos
Doenças dos Cavalos/epidemiologia , Aborto Animal/epidemiologia , Animais , Animais Recém-Nascidos , Cruzamento , Colostro/imunologia , Feminino , Doenças Fetais/epidemiologia , Doenças Fetais/mortalidade , Doenças Fetais/veterinária , Alemanha/epidemiologia , Nível de Saúde , Doenças dos Cavalos/mortalidade , Cavalos , Imunoglobulina G/análise , Imunoglobulina G/sangue , Infecções/epidemiologia , Infecções/mortalidade , Infecções/veterinária , Gravidez
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA